Cargando…
Surgery including fertility-sparing treatment of GTD
Gestational trophoblastic disease (GTD) consists of a spectrum of diseases, including hydatidiform moles, invasive mole, metastatic mole, choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). GTD is a relatively uncommon disease occurring in women of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547826/ https://www.ncbi.nlm.nih.gov/pubmed/33127305 http://dx.doi.org/10.1016/j.bpobgyn.2020.10.005 |
_version_ | 1783592502773678080 |
---|---|
author | Ngu, Siew-Fei Ngan, Hextan Y.S. |
author_facet | Ngu, Siew-Fei Ngan, Hextan Y.S. |
author_sort | Ngu, Siew-Fei |
collection | PubMed |
description | Gestational trophoblastic disease (GTD) consists of a spectrum of diseases, including hydatidiform moles, invasive mole, metastatic mole, choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). GTD is a relatively uncommon disease occurring in women of reproductive age, with high cure rates. Primary treatment of hydatidiform moles includes uterine evacuation, followed by close monitoring of serial hCG levels to detect for post-molar gestational trophoblastic neoplasia (GTN). In patients with GTN, the main therapy consists of chemotherapy, although some surgical procedures are important in selected patients to achieve curing. Hysterectomy is the mainstay treatment for PSTT or ETT and may be considered in selected patients for management of hydatidiform mole and malignant GTN especially in chemoresistant disease. Resection of metastatic lesions such as in the lung or brain can be considered in selected patients with isolated chemoresistant tumour. Surgical treatment of GTD will be discussed in this chapter. |
format | Online Article Text |
id | pubmed-7547826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75478262020-10-13 Surgery including fertility-sparing treatment of GTD Ngu, Siew-Fei Ngan, Hextan Y.S. Best Pract Res Clin Obstet Gynaecol 7 Gestational trophoblastic disease (GTD) consists of a spectrum of diseases, including hydatidiform moles, invasive mole, metastatic mole, choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). GTD is a relatively uncommon disease occurring in women of reproductive age, with high cure rates. Primary treatment of hydatidiform moles includes uterine evacuation, followed by close monitoring of serial hCG levels to detect for post-molar gestational trophoblastic neoplasia (GTN). In patients with GTN, the main therapy consists of chemotherapy, although some surgical procedures are important in selected patients to achieve curing. Hysterectomy is the mainstay treatment for PSTT or ETT and may be considered in selected patients for management of hydatidiform mole and malignant GTN especially in chemoresistant disease. Resection of metastatic lesions such as in the lung or brain can be considered in selected patients with isolated chemoresistant tumour. Surgical treatment of GTD will be discussed in this chapter. Published by Elsevier Ltd. 2021-07 2020-10-10 /pmc/articles/PMC7547826/ /pubmed/33127305 http://dx.doi.org/10.1016/j.bpobgyn.2020.10.005 Text en © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 7 Ngu, Siew-Fei Ngan, Hextan Y.S. Surgery including fertility-sparing treatment of GTD |
title | Surgery including fertility-sparing treatment of GTD |
title_full | Surgery including fertility-sparing treatment of GTD |
title_fullStr | Surgery including fertility-sparing treatment of GTD |
title_full_unstemmed | Surgery including fertility-sparing treatment of GTD |
title_short | Surgery including fertility-sparing treatment of GTD |
title_sort | surgery including fertility-sparing treatment of gtd |
topic | 7 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547826/ https://www.ncbi.nlm.nih.gov/pubmed/33127305 http://dx.doi.org/10.1016/j.bpobgyn.2020.10.005 |
work_keys_str_mv | AT ngusiewfei surgeryincludingfertilitysparingtreatmentofgtd AT nganhextanys surgeryincludingfertilitysparingtreatmentofgtd |